1.16 -0.04 (-3.23%)
RODM
Stock Details
Last Trade:1.16 Change:-0.04 (-3.23%) Prev Close:1.20 Open: 1.24 Days Range:1.15 – 1.25 52 Week Range: 0.14 - 2.99 Volume:96016 P/E: 38.67EPS:0.03
View AllRecent Alerts 07/04/09
Recent Alert on 07/01/09 at 8:06am
Skystar Bio-Pharmaceutical (SKBI) Prices 1.4M Shares At $12.98 A Share
Skystar Bio-Pharmaceutical (SKBI) Prices 1.4M Shares At $12.98 A Share
Skystar Bio-Pharmaceutical Co., Ltd. (NASDAQ: SKBI) announced that it has priced its public offering of 1,400,000 shares of common stock. Skystar has granted the representative of the underwriters a 45-day option to purchase up to an additional... Read More
Recent Alert on 06/18/09 at 7:50am
Spectrum Pharmaceuticals (SPPI) Receives $10 Million from Two Institutional Investors at $5.83 Per Share
Spectrum Pharmaceuticals (SPPI) Receives $10 Million from Two Institutional Investors at $5.83 Per Share
Recent Alert on 06/18/09 at 7:50am
Spectrum Pharmaceuticals (SPPI) Receives $10 Million from Two Institutional Investors at $5.83 Per Share
Spectrum Pharmaceuticals (SPPI) Receives $10 Million from Two Institutional Investors at $5.83 Per Share
Recent Alert on 05/26/09 at 7:26am
Vical (VICL) Receives Additional Commitment in Registered Direct Offering
Vical (VICL) Receives Additional Commitment in Registered Direct Offering
View AllRecent Press Releases
Press Release on 07/01/09 at 7:31pm
Skystar Bio-Pharmaceutical Announces Exercise of Over-Allotment Purchase Option
Skystar Bio-Pharmaceutical Announces Exercise of Over-Allotment Purchase Option
Press Release on 07/01/09 at 12:51pm
Spectrum Pharmaceuticals to Raise $21 Million from Institutional Investors at $7.1525 Per Share
Spectrum Pharmaceuticals to Raise $21 Million from Institutional Investors at $7.1525 Per Share
Press Release on 07/01/09 at 12:44pm
Skystar Bio-Pharmaceutical Announces Pricing of Public Offering of Common Stock
Skystar Bio-Pharmaceutical Announces Pricing of Public Offering of Common Stock
Press Release on 07/01/09 at 8:00am
Rodman & Renshaw Capital Group, Inc. Schedules Conference Call to Discuss Preliminary Financial Results for the Second Quarter of 2009
Rodman & Renshaw Capital Group, Inc. Schedules Conference Call to Discuss Preliminary Financial Results for the Second Quarter of 2009
Press Release on 06/30/09 at 9:29pm
Spectrum Pharmaceuticals to Raise $21 Million from Institutional Investors at $7.1525 Per Share
Spectrum Pharmaceuticals to Raise $21 Million from Institutional Investors at $7.1525 Per Share
View AllRecent SEC Filings
No Recent SEC Filings Available